Elon Musk's Neuralink is set to launch its first international clinical trial in the UAE, in partnership with the Cleveland Clinic, aimed at aiding communication for individuals with motor and speech impairments through thought control. This announcement was made immediately prior to President Donald Trump's arrival in the region, coinciding with another expansion news from Musk's Starlink, which has received approvals in Saudi Arabia. These developments underscore the increasing connection between technological advancements and international business relationships, particularly in the context of Trump's tour for investment conversations.
Neuralink is launching a clinical trial in the UAE, which focuses on using thought control for communication, marking its first trial outside the US.
The launch of Neuralink's trial coincides with President Trump's tour of the Gulf, indicating potential ties between tech advancements and international trade deals.
Collection
[
|
...
]